Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis
Abstract
The objective of this meta-analysis was to indirectly compare incidence of nephrotoxicity in trials using cisplatin (CIS) for treatment of solid tumors when renal function was assessed using serum creatinine (SCr) or creatinine clearance (CrCl) for eligibility criteria.
Authors:
Dahal A, Bellows BK, Sonpavde G, Tantravahi SK, Choueiri TK, Galsky M, Agarwal NJournal/Publisher:
Am J Clin OncolEdition:
May 2014. 39(5):497-506. doi: 10.1097/COC.0000000000000081Link to Article
Access the article here: Am J Clin OncolCitation:
Dahal A, Bellows BK, Sonpavde G, Tantravahi SK, Choueiri TK, Galsky M, Agarwal N. Incidence Of Severe Nephrotoxicity With Cisplatin Based On Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis. Am J Clin Oncol. May 2014 39(5):497-506. doi: 10.1097/COC.0000000000000081